Compare RGC & BXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGC | BXP |
|---|---|---|
| Founded | 2014 | 1970 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 11.5B |
| IPO Year | 2021 | 1997 |
| Metric | RGC | BXP |
|---|---|---|
| Price | $20.92 | $67.68 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 18 |
| Target Price | N/A | ★ $77.61 |
| AVG Volume (30 Days) | 328.1K | ★ 1.3M |
| Earning Date | 10-24-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 4.15% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,425,025,000.00 |
| Revenue This Year | N/A | $3.30 |
| Revenue Next Year | N/A | $1.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.42 |
| 52 Week Low | $0.09 | $54.22 |
| 52 Week High | $83.60 | $79.33 |
| Indicator | RGC | BXP |
|---|---|---|
| Relative Strength Index (RSI) | 57.60 | 37.78 |
| Support Level | $19.80 | $68.55 |
| Resistance Level | $25.50 | $69.65 |
| Average True Range (ATR) | 2.71 | 1.23 |
| MACD | 0.13 | -0.18 |
| Stochastic Oscillator | 47.37 | 14.24 |
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.